You can buy or sell DURECT and other stocks, options, ETFs, and crypto commission-free!
DURECT Corporation Common Stock, also called DURECT, is a biopharmaceutical company. It engages in the research, development, and manufacturing of pharmaceutical products. Read More The company products include alzet and lactel. Its pipeline includes DUR-928, which focuses on lipid homeostasis, inflammation, and cell survival; and POSIMIR, which is an analgesic product intended to deliver bupivacaine to provide pain relief after surgery. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA. The listed name for DRRX is DURECT Corporation Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 2, After Hours